Ibogaine Research

In an informal survey of people who have used ibogaine, respondents…

Found it more helpful than other things that they tried. 93%
Would describe the experience as "life changing." 97%
Found the experience beneficial. 100%

Ceiba’s ongoing research projects

One of Ceiba’s primary commitments is to improving the quality of iboga- and ibogaine-assisted therapies. Our research programs are currently focused on mixed methods analysis of research questions that are likely to help us better understand the ibogaine experience and to inform clinical best practices.

Have you ever taken iboga or ibogaine?

Quick Survey
This is a short, informal, and non-scientific survey. Results are displayed anonymously.

Did you take iboga or ibogaine in the last 48-hours?

Ibogaine Experience Scale (IES)
A questionnaire being developed in partnership with the International Center for Ethnobotanical Education, Research and Service (ICEERS) to assess the acute subjective effects of ibogaine. Takes approximately: 20 minutes to complete.


Are you a US citizen or resident that is planning to travel outside the US to take iboga or ibogaine in the near future?

Exploring the Oneirogenic Experience in Ibogaine Therapy
This is a mixed-method observational study that seeks to explore the nature of the oneirogenic experience stimulated by ibogaine, and to make an exploratory assessment of some factors that influence this experience. Takes approximately 6-8 hours of your time, over a 6 week period.

This study has completed enrollment and data collection. Thank you to all those who participated!


The following are a few scientific papers that Ceiba Foundation and its leadership have been involved in.

Wilson, C., Millar, T., & Matieschyn, Z. (2021). Novel treatment of opioid use disorder using ibogaine and iboga in two adults. Journal of Psychedelic Studies.


Krengel, F., Dickinson, J., Jenks, C., Reyes-Chilpa, R. (2020). Quantitative Evaluation of a Mexican and a Ghanaian Tabernaemontana Species as Alternatives to Voacanga africana for the Production of Antiaddictive Ibogan Type Alkaloids. Chemistry and Biodiversity.


Krengel, F., Chevalier, Q., Dickinson, J., Herrera-Santoyo, J., Olivera-Flores, T., Reyes-Chilpa, R. (2019). Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae). Chemistry and Biodiversity, 16(4):e18005.


Dickinson, J. (2016). Iboga Root: Dynamics of Iboga’s African Origins and Modern Medical Use. HerbalGram: The Journal of the American Botanical Council.


Cloutier-Gill, L., Wood, E., Millar, T., Ferris, C., Socias, M.E. (2016). Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report, Journal of Psychoactive Drugs.


Dickinson, J., McAlpin, J., Wilkins, C., Fitzsimmons, C., Paterson, T., Greene, D., Chaves, B.R. (2015). Clinical Guidelines for Ibogaine-Assisted Detoxification. The Global Ibogaine Therapy Alliance.


Stay in touch with us

Contact Us Make a Donation

Quick Information

Privacy Policy

Follow Us

Log in with your credentials


Forgot your details?

Create Account